PolyNovo Investor Relations Material
Latest events
Investor Update
PolyNovo
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PolyNovo Limited
Access all reports
PolyNovo Limited is an Australian medical device company specializing in the development and manufacturing of advanced wound care solutions using its proprietary NovoSorb biodegradable polymer technology. The company's flagship product, NovoSorb Biodegradable Temporizing Matrix (BTM), is designed to support dermal regeneration in patients who have suffered tissue loss due to burns, trauma, or surgical procedures. NovoSorb BTM is utilized in various medical applications, including the treatment of complex wounds, chronic ulcers, and surgical wounds. Additionally, PolyNovo is expanding its product portfolio to include applications in hernia repair and other reconstructive surgeries. PolyNovo Limited is headquartered in Port Melbourne, Victoria, Australia, and its shares are listed on the Australian Securities Exchange.
Key slides for PolyNovo Limited
H1 2025
PolyNovo Limited
Investor Update
PolyNovo Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PNV
Country
🇦🇺 Australia